Abstract
Despite decades of research, heart disease remains a burden on global health, especially in developed countries. Among problematic cardiovascular indications, abnormal heart rhythms or arrhythmias play a significant role. Dofetilide is a unique cardiovascular drug and one of the earliest antiarrhythmic agents. For many years, compounds labelled with tritium have been extremely useful to facilitate drug discovery research at the receptor level. This paper describes the tritium labelling of dofetilide by several methods. The syntheses and characterization of [phenyl-3H] dofetilide as well as [N-methyl-3H] dofetilide are described in detail. ESI mass spectrometry was found to be an especially useful analytical tool to characterize these valuable radioligands. Because of synthetic efficiency and high specific activity, [N-methyl-3H] dofetilide emerged as the preferred radioligand used by biologists worldwide and information about its storage and stability are also discussed.
Similar content being viewed by others
References
Mahmood SS, Levy D, Vasan RS, Wang TJ (2014) The Framingham heart study and the epidemiology of cardiovascular diseases: a historical perspective. Lancet 383(9921):999–1008
Palagyi A, de Silva HA, Praveen D, Patel A (2019) Combatting the global crisis of cardiovascular disease. Heart Lung Circ 28(7):981–983
Falk RH, DeCara JM (2000) Dofetilide: a new pure class III antiarrhythmic agent. Am Heart J 140(5):697–706
Hulme EC, Trevethick MA (2010) Ligand binding assays at equilibrium: validation and interpretation. Brit J Pharmacol 161(6):1219–1237
Egan JA, Filer CN (2004) An efficient synthesis of the ACE inhibitor [phenyl-3H] lisinopril. Synth Commun 34(13):2473–2477
Egan JA, Souza SM, Filer CN (2004) A facile synthesis of [tetrahydrofuran-3H] terazosin. Synth Commun 34(10):1881–1884
Egan JA, Filer CN (2003) Tritium labelling and characterization of the potent imidazoline I1 receptor antagonist [5,7–3H] (+/-)-efaroxan at high specific activity. Appl Radiat Isot 58(6):675–677
Liu H, Ji M, Luo X, Shen J, Huang X, Hua W, Jiang H, Chen K (2002) New p-methylsulfonamido phenylethylamine analogues as class III antiarrhythmic agents: design, synthesis, biological assay, and 3D-QSAR analysis. J Med Chem 45(14):2953–2969
Filer CN (2018) Synthesis and characterization of tritium-labelled substances. Appl Radiat Isot 137:261–272
Matta MK, Narayanasamy S, Vicente J, Zusterzeel R, Patel V, Strauss DG (2020) Novel high-throughput quantitation of potent hERG blocker dofetilide in human plasma by liquid chromatography-tandem mass spectrometry: application in a phase 1 ECG biomarker validation study. J Anal Toxicol 44(2):180–187
Wright P, Alex A, Harvey S, Parsons T, Pullen F (2013) Understanding collision-induced dissociation of dofetilide: a case study in the application of density functional theory as an aid to mass spectral interpretation. Analyst 138(22):6869–6880
Steckel A, Schlosser G (2019) An organic chemist’s guide to electrospray mass spectrometric structure elucidation. Molecules 24(3):611
Balabanovich AI, Luda MP, Operti L (2005) GC/MS identification of pyrolysis products from fire-retardant brominated epoxy resin. J Fire Sci 23(3):227–245
Kruve A, Kaupmees K (2017) Adduct formation in ESI/MS by mobile phase additives. J Am Soc Mass Spectrom 28(5):887–894
Olofson RA, Martz JT, Senet J-P, Piteau M, Malfroot T (1984) A new reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine. J Org Chem 49(11):2081–2082
Olofson RA, Schnur RC, Bunes L, Pepe JP (1977) Selective N-dealkylation of tertiary amines with vinyl chloroformate: an improved synthesis of naloxone. Tetrahedron Lett 18:1567–1570
Hageman H (1953) The von Braun cyanogen bromide reaction. Org React 7:198–262
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Regarding this submitted manusript, the authors know of no competing financial interests or personal relationships which could have influenced the work reported.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Egan, J.A., Filer, C.N. & Pounds, S. Dofetilide: tritium labelling by several methods. J Radioanal Nucl Chem 333, 2081–2087 (2024). https://doi.org/10.1007/s10967-024-09415-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-024-09415-8